Johnson & Johnson’s $5.5 Billion Talc Settlement: What It Does Not Cover
On July 27, 2026, Johnson & Johnson announced a proposed $5.5 billion resolution of the ovarian cancer talc claims consolidated in federal court in New Jersey and in related state court cases. The agreement is conditioned on at least 95 percent of remaining claimants participating, and it pays nothing until 2027. It does not resolve …





